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Exercise performance in patients with peripheral
arterial disease who have different types of
exertional leg pain
Andrew W. Gardner, PhD,a,c,d Polly S. Montgomery, MS,a,c,d and Azhar Afaq, MD,b Oklahoma City,
Okla; and Baltimore, Md
Objective: This study compared the exercise performance of patients with peripheral arterial disease (PAD) who have
different types of exertional leg pain.
Methods: Patients with PAD were classified into one of four groups according to the San Diego Claudication Question-
naire: intermittent claudication (n  406), atypical exertional leg pain causing patients to stop (n  125), atypical
exertional leg pain in which patients were able to continue walking (n 81), and leg pain on exertion and rest (n 103).
Patients were assessed on the primary outcome measures of ankle-brachial index (ABI), treadmill exercise measures, and
ischemic window.
Results: All patients experienced leg pain consistent with intermittent claudication during a standardized treadmill test.
The mean ( SD) initial claudication distance (ICD) was similar (P  .642) among patients with intermittent
claudication (168  160 meters), atypical exertional leg pain causing patients to stop (157  130 meters), atypical
exertional leg pain in which patients were able to continue walking (180 149 meters), and leg pain on exertion and rest
(151 136 meters). The absolute claudication distance (ACD) was similar (P .648) in the four respective groups (382
 232, 378  237, 400  245, and 369  236 meters). Similarly, the ischemic window, expressed as the area under the
curve (AUC) after treadmill exercise, was similar (P .863) in these groups (189 137, 208 183, 193 143, and 199
 119 AUC).
Conclusion: PAD patients with different types of exertional leg pain, all limited by intermittent claudication during a
standardized treadmill test, were remarkably similar in ICD, ACD, and ischemic window. Thus, the presence of
ambulatory symptoms should be of primary clinical concern in evaluating PAD patients regardless of whether they are
consistent with classic intermittent claudication. (J Vasc Surg 2007;46:79-86.)Symptomatic peripheral arterial disease (PAD), which
affects 6% of the American population 55 years old,1 is a
leading cause of morbidity.2 Patients experience lower ex-
tremity pain during ambulation because the impaired cir-
culation cannot meet the energy needs of the active mus-
culature. As a consequence, these patients have ambulatory
dysfunction,3-6 decline in other domains of physical func-
tion,7-10 lower daily physical activity,11 impaired health-
related quality of life,12,13 and difficulty in completing
activities of daily living that require the use of the lower
extremities.14
A widely recognized symptom of PAD is intermittent
claudication, defined as ischemic calf pain that occurs dur-
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doi:10.1016/j.jvs.2007.02.037ing ambulation and resolves 10 minutes of rest.15 How-
ever, patients with PAD are often asymptomatic or have
symptoms that are atypical from the classic description of
intermittent claudication.16-18 Recent studies have com-
pared PAD patients with different types of exertional leg
pain on various measures of functional status.19-21 Patients
with intermittent claudication have worse functional status,
self-reported ambulatory function, and health-related qual-
ity of life than patients with atypical pain,21 but better
values than those reporting leg pain on exertion and
rest.20,21 These measures, which are either subjective or are
based on self-paced exercise tasks, do not provide the level
of standardization as does a treadmill test to compare
claudication distances and peripheral vascular function
among groups with different types of exertional pain.
To our knowledge, no study to date has examined
exercise performance and peripheral hemodynamic re-
sponses in these patients during a standardized treadmill
test. Thus, the primary purpose of this study was to com-
pare the exercise performance of patients with PAD who
have different types of exertional leg pain. An additional
aim was to compare secondary measures, such as physical
function, physical activity, health-related quality of life, and
peripheral vascular reactivity, in patients with different
types of exertional leg pain.
METHODS
Screening. A total of 905 PAD patients with symp-
toms of leg pain were evaluated in the Geriatrics, Research,
79
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Affairs Health Care System (MVAHCS) at Baltimore. Pa-
tients were recruited from the vascular clinic at the site of
the BaltimoreMVAHCS and from advertisements. Patients
were included if they had Fontaine stage II PAD,22 defined
by the inclusion criteria of a history of leg pain, ambulation
during a graded treadmill test limited by leg pain,23 and an
ankle-brachial index (ABI) at rest of0.90.1 Patients were
excluded for absence of PAD (ABI 0.90), inability to
obtain an ABI measure due to noncompressible vessels,
asymptomatic PAD (Fontaine stage I), use of medications
indicated for the treatment of intermittent claudication
(cilostazol and pentoxifylline)3 months before investiga-
tion, exercise tolerance limited by factors other than leg
pain (eg, severe coronary artery disease, dyspnea, poorly
controlled blood pressure), and active cancer, renal disease,
or liver disease.
A total of 715 patients were deemed eligible for this
investigation, and 190 patients were ineligible. All patients
lived independently at home and completed all of the
assessments described below in1 week. The Institutional
Review Boards at the University of Maryland and the
MVAHCS at Baltimore approved the procedures used in
this study. Written informed consent was obtained from
each patient before investigation.
Exertional leg symptom groups. Leg symptoms
were evaluated by administering the San Diego Claudica-
tion Questionnaire,24 a standardized and validated 11-item
questionnaire based on the Rose questionnaire for inter-
mittent claudication.15 According to the responses from
the San Diego Claudication Questionnaire, PAD patients
were placed into one of the four exertional leg symptom
groups: (1) leg pain on exertion that sometimes begins at
rest (leg pain on exertion and rest group, n 103), (2) leg
pain on exertion that does not begin at rest, causes the
patient to stop or slow down, but does not fulfill the
remaining criteria for intermittent claudication (atypical
exertional leg pain/stop group, n  125), (3) leg pain on
exertion that does not begin at rest and does not cause the
patient to stop or slow down (atypical exertional leg pain/
carry-on group, n  81), and (4) leg pain on exertion that
does not begin at rest, causes the patient to stop or slow
down, is located in the calves, does not resolve while
walking, and goes away 10 minutes of rest (intermittent
claudication group, n  406).19,20,21,25,26
Medical history. Demographic information, height,
weight, cardiovascular risk factors, comorbid conditions,
claudication history, and a list of current medications were
obtained during a physical examination andmedical history
interview to begin the evaluation.
Claudication distances and peak oxygen uptake.
Patients performed a progressive, graded treadmill protocol
(2 miles/hour, 0% grade with 2% increase every 2 minutes)
until maximal claudication pain, as previously described.23
The initial claudication distance (ICD), absolute claudica-
tion distance (ACD), time to relief of claudication pain after
the test, and peak oxygen uptake were measured. The
test-retest intraclass reliability coefficient with these proce-dures is R  0.89 for ICD,23 R  0.93 for ACD23, and R
 0.88 for peak oxygen uptake.27
Walking economy and fractional utilization.
Oxygen uptake was measured during a constant, submaxi-
mal work rate at a treadmill speed of 2 miles/hour and a
grade of 0% until maximal claudication pain, or for a
maximum of 20 minutes.28 Walking economy was mea-
sured as the oxygen uptake obtained during the final
minute of the test. To quantify the intensity of the walking
economy test as a percentage of peak capacity, fractional
utilization was calculated as the walking economy oxygen
uptake/peak oxygen uptake.
Ankle-brachial index and ischemic window. As pre-
viously described, the ABI was obtained from the more
severely diseased lower extremity by the Doppler ultra-
sound technique before and at 1, 3, 5, and 7 minutes after
each treadmill test.29 The reduction in ankle systolic blood
pressure after treadmill exercise from the resting baseline
value was quantified by calculating the area under the curve
(AUC), referred to as the ischemic window.30
Six-minute walk distances. Patients performed an
over-the-ground, 6-minute walk test supervised by trained
exercise technicians, as previously described.31 The pain-
free and total distance walked during the test were re-
corded. The test-retest intraclass reliability coefficient is R
 0.75 for the distance to onset of claudication pain, andR
 0.94 for the total 6-minute walking distance.31
Walking Impairment Questionnaire. Self-reported
ambulatory ability was assessed by using Walking Impair-
ment Questionnaire, a validated questionnaire for PAD
patients that assesses the subject’s ability to walk at various
speeds and distances and to climb stairs.10
Short Physical Performance Battery. The Short
Physical Performance Battery score was calculated from the
performance of a 4-meter walk test, a chair stand test, and a
standing balance test as previously described.32,33 Briefly,
during the 4-meter walk test, walking velocity was assessed
by measuring the time required for subjects to walk a
distance of 4 meters marked out in a corridor at their usual
pace. Patients performed this test twice, and the faster of
the two walks was used for analysis. During the chair stand
test, lower extremity strength and balance were assessed by
performing a repeated chair rise test in which patients
completed five sequential sit-to-stand transfers from an
armless 18-inch high, straight-backed chair with their arms
folded across their chest. During the standing balance test,
balance was assessed by measuring the time that patients
could hold a stance in side-by-side, semi-tandem, and
full-tandem positions.
For each of the three tests, patients were scored on a 0
to 4 ordinal scale, with a score of 0 representing inability to
perform the test and scores between 1 and 4 representing
quartiles of performance based on normative data on
5000 community-dwelling people published from the
Established Populations for the Epidemiologic Studies of
the Elderly.32 The Short Physical Performance Battery
score ranges from 0 to 12 (0  worst function, 12  best
function) and is predictive of mobility loss, nursing home
resent
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derly individuals.32,33 The test-retest intraclass reliability
coefficient is R  0.93 for the Short Physical Performance
Battery score.34
Self-perceived health. The Health Utilities Index,
ranging between 0 (the worst imaginable health) and 100
(the best imaginable health), was used to assess self-re-
ported health, as previously described.35 Patients were
asked to select a numeric value on the scale that best
corresponded to their current overall health state.
Daily physical activity. Physical activity level was
monitored over two consecutive weekdays by a Caltrac
accelerometer (Muscle Dynamics, Torrance, Calif) at-
tached to the belt of each subject, as previously described.36
In addition, a physical activity scale was used to assess the
self-reported physical activity level over the preceding
month, as previously described.11,37 The accelerometer
measure of physical activity has a test-retest intraclass reli-
ability coefficient of R  0.8437 and provides a valid
estimate of daily physical activity assessed by the gold
standard technique of doubly labeled water.36
Quality of life. Health-related quality of life was as-
sessed with the Medical Outcomes Study Short-Form 36
(MOS SF-36) General Health Survey.38 TheMOS SF-36 is
a reliable and valid generic instrument that includes multi-
item scales measuring the eight health domains of physical
function, role limitations due to physical problems, general
health, bodily pain, social function, role limitations due to
emotional problems, mental health, and vitality. For each
subscale, item scores were recorded, summed, and stan-
dardized into a scale from 0 to 100, with better health states
resulting in higher scores.
Calf blood flow. Calf blood flow was obtained at rest
and after 3 minutes of arterial occlusion (ie, reactive hyper-
emia) in the more severely diseased leg using venous occlu-
sion mercury strain-gauge plethysmography, as previously
described.39 The test-retest intraclass reliability coefficient
Table I. Clinical characteristics of patients with peripheral
Variables
Leg pain group on
exertion and rest
group (n  103)
A
Stop (
Age (years) 67  7 69
Weight (kg) 82.4  16.8 83.0
Body mass index (kg/m2) 28.1  5.0 28.2
Ankle-brachial index 0.71  0.19 0.68
Leg pain duration (years) 4.5  5.2 5.3
Sex (% men) 78
Race (% white) 59
Current smoking 33
Diabetes 35
Hypertension 65
Hyperlipidemia 43
Abdominal obesity 44
Obesity† 37
*Continuous values are presented as means  SD; categoric variables are p
†Obesity was defined as having a body mass index 30 kg/m2.is R  0.86 for calf blood flow.39Transcutaneous oxygen tension. Transcutaneous
oxygen tension (TcPO2) was measured at rest and after 3
minutes of arterial occlusion on the medial portion of the
calf musculature of the more affected leg with a Clark-type
polarographic electrode and a TcPO2Monitor (Novametrix
Medical System, Model 818, Wallingford, Conn). The
change in calf TcPO2 after arterial occlusion is a measure of
the ischemic response to this test. The test-retest intraclass
reliability coefficient is R  0.87 for calf TcPO2.
27
Statistical analyses. One-factor analysis of variance
(ANOVA) and 2 tests were used to assess whether
differences in clinical characteristics existed among the
four groups of PAD patients with exertional leg symp-
toms. All of the ANOVA tests met the assumption of
having normally distributed data. A significant main
effect in the ANOVA was followed by Tukey post hoc
comparisons to compare pair-wise differences among the
group means. All analyses were performed using
SPSS-PC statistical software (SPSS Inc, Chicago, Ill).
Statistical significance was set at P  .05. Measurements
are presented as means  standard deviations.
RESULTS
Patients with PAD were classified into four groups
according to their exertional leg pain. The clinical charac-
teristics of these groups are summarized in Table I. The
ABI and duration of leg pain were similar (P  .005) in all
groups. The groups were also similar with respect to age,
sex, racial composition, current smoking status, cardiovas-
cular risk factors, and measures of body mas.
The measurements obtained during standardized
treadmill tests in the patients with PAD are listed in
Table II. All patients experienced exertional leg pain
during the treadmill tests. The pain was consistent with
intermittent claudication, because walking was discon-
tinued due to calf leg pain that resolved during subse-
quent rest. The ICD, ACD, time to relief of claudication
rial disease placed in four exertional leg symptom groups*
al exertional leg pain groups
Intermittent
claudication
group
(n  406) P125) Carry on (n  81)
68  9 68  8 .858
6.3 80.9  16.7 82.1  15.1 .344
.9 27.5  5.0 28.4  4.5 .200
.21 0.69  0.23 0.68  0.22 .429
.7 4.9  6.2 4.6  4.8 .531
86 79 .252
59 65 .621
37 36 .403
36 38 .745
64 66 .298
39 45 .637
35 39 .346
33 35 .521
ed as percentages.arte
typic
n 
 9
 1
 4
 0
 6
82
58
32
32
61
43
38
32pain, and peak oxygen uptake values obtained from the
; AUC
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groups (P  .05). The walking economy and fractional
utilization measures obtained during treadmill walking
were also similar (P  .05), as was the ischemic window
obtained immediately after both the progressive, graded
treadmill test, and the submaximal work-rate treadmill
test (P  .05).
Physical function, self-reported health, and physical
activity levels of patients with PAD placed in four exertional
Table II. Treadmill measurements of patients with periph
groups*
Variables
Leg pain on exertion
and rest group
(n  103)
Atypi
Stop (n
ICD (meters) 151  136 157 
ACD (meters) 369  236 378 
Time to relief of claudication
pain (min:sec) 7:52  4:20 7:21 
Peak oxygen uptake
(mL/[kg · min]) 13.9  2.6 14.1 
Walking economy
(mL/[kg · min]) 12.3  3.8 12.2 
Fractional utilization (%) 88  17 87 
Ischemic window
After graded treadmill test
(AUC) 199  119 208 
After walking economy test
(AUC) 122  117 119 
ICD, Intermittent claudication distance; ACD, actual claudication distance
*Values are means  SD.
Table III. Physical function, self-reported health, and phy
placed in four exertional leg symptom groups*
Variables
Leg pain on exertion
and rest group (n 
103)
Atypical
Stop
(n  125
Six-minute walk
Pain-free distance
(meters) 178  128 189  12
Distance (meters) 342  94† 385  94
WIQ scores
Distance (%) 30  32 32  33
Speed (%) 33  31 34  26
Stair climbing (%) 37  33 38  38
Short Physical
Performance
Battery score
(units) 9.5  1.9† 10.2  2.
Self-Perceived Health
(%) 67  17 70  21
Physical Activity Scale
(units) 1.1  0.9† 1.4  1.
Daily Physical Activity
(kcal/day) 268  185† 351  19
WIQ, Walking Impairment Questionnaire.
*Values are means  SD.
†Significantly lower than the other groups (P  .008).leg pain groups are summarized in Table III. The groupwith leg pain on exertion and rest had a shorter 6-minute
walking distance, a lower Short Physical Performance Bat-
tery score, and lower physical activity values than each of
the other three groups (P  .05). The pain-free distance
during the 6-minute walk test, each score from theWalking
Impairment Questionnaire, and self-reported heath were
similar in the four groups (P  .05). Measures of health-
related quality of life (Table IV) as well as calf blood flow
and transcutaneous oxygen tension (Table V) were also
rterial disease placed in four exertional leg symptom
ertional leg pain groups
Intermittent claudication
group (n  406) P5) Carry on (n  81)
180  149 168  160 .642
400  245 382  232 .648
6 6:31  4:15 7:28  4:01 .893
14.4  3.6 14.8  3.7 .505
11.3  2.0 12.0  2.7 .330
82  16 84  18 .466
193  143 189  137 .863
113  109 112  94 .955
, area under curve.
activity level of patients with peripheral arterial disease
onal leg pain groups
Intermittent
Claudication Group (n 
406) PCarry on (n  81)
196  138 187  131 .922
394  106 376  95 .018
36  35 33  34 .936
36  30 34  27 .630
41  34 39  35 .702
10.8  2.2 10.1  2.1 .020
75  19 70  19 .172
1.6  1.1 1.5  1.1 .037
370  231 337  211 0.049eral a
cal ex
 12
130
237
4:1
3.0
4.6
20
183
114sical
exerti
)
4
0
2
4similar (P  .05).
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The major findings of this investigation were (1) all
patients experienced symptoms during the treadmill test
consistent with classic intermittent claudication, suggesting
that patients in the three atypical pain groups are misreport-
ing their symptoms, (2) exercise performance during a
standardized treadmill test was similar among all exertional
leg pain groups, and (3) physical function and daily physical
activity were lowest in patients who reported leg pain on
exertion and rest.
To our knowledge, this study is the first to quantify and
compare the treadmill exercise performance of PAD pa-
tients with different types of exertional leg pain. A key
observation was that during a standardized treadmill test,
patients who had leg symptoms atypical from classic inter-
mittent claudication were limited in their exercise perfor-
mance by ischemic leg pain consistent with intermittent
claudication, which resolved soon after exercise. The simi-
lar walking distances to the onset of leg pain and tomaximal
tolerable leg pain in all four groups, as well as the similar
cardiopulmonary function and walking economymeasures,
indicate that the PAD symptom subtype had little impact
on standardized exercise performance. Finally, the ischemic
Table IV. Health-related quality-of-life measurements of
exertional leg symptom groups*
Variables
Leg pain on exertion and
rest group (n  103)
At
Stop
Physical Function 49  22 6
Role Limitations–Physical 63  38 3
Bodily Pain 54  20 6
General Health 60  22 6
Social Function 75  21 8
Role Limitations–Emotional 67  44 5
Mental Health 80  15 8
Vitality 63  22 6
*Values are means  SD.
Table V. Peripheral hemodynamic measurements of patie
symptom groups*
Variables
Leg Pain on exertion
and rest group (n 
103)
A
(n
Calf blood flow
Rest (%/min) 2.82  1.42 3.47
Hyperemia (%/min) 8.14  4.87 8.42
Change from rest to hyperemia
(%) 198  111 161
Calf TcPO2
Rest (mm Hg) 35  18 40
Hyperemia (mm Hg) 25  20 31
Change from rest to hyperemia (%) 29  31 23
TcPO2, Transcutaneous oxygen pressure.
*Values are means  SD.window values obtained after treadmill exercise confirmthat the exertional leg pain in each group was of vascular
origin and that ambulation was limited by peripheral vas-
cular insufficiency to a similar extent regardless of leg pain
subtype. Therefore, the stratification of patients into vari-
ous leg pain subgroups is not useful in distinguishing
among patients on standard PAD-related outcome mea-
sures such as ICD, ACD, ABI, and the ischemic window.
The similarity in exercise performance in all groups
during standardized treadmill exercise suggests that pa-
tients who report atypical exertional leg pain should be
considered as if they have classic intermittent claudication.
As such, these patients should undergo similar medical
management even if their description of exertional leg pain
does not meet every criterion of classic intermittent claudi-
cation.
It is not clear why symptoms vary among claudicant
patients. One possibility is that the patients do not fully
understand the questions on the San Diego Claudication
Questionnaire, and consequently, they misreport their
symptoms. The variation may be due to differences in
walking patterns in the community setting. For example, to
be defined as having classic intermittent claudication on the
San Diego Claudication Questionnaire, patients must an-
nts with peripheral arterial disease placed in four
exertional leg pain groups
Intermittent claudication
group (n  406) P125) Carry on (n  81)
6 57  25 55  22 .597
5 59  42 57  42 .769
2 62  21 57  24 .995
9 61  22 59  22 .439
9 81  22 79  24 .706
6 74  38 67  41 .253
3 77  17 78  16 .724
9 62  19 60  21 .539
ith peripheral arterial disease placed in four exertional leg
al exertional leg pain groups
Intermittent claudication
group (n  406) P5)
Carry on group
(n  81)
.57 3.46  1.70 3.59  1.70 .363
.70 8.84  4.59 9.31  4.18 .200
18 174  125 188  149 .190
7 43  16 37  17 .338
1 30  32 24  17 .111
8 30  31 35  28 .240patie
ypical
(n 
6  1
8  3
0  2
8  1
3  1
0  3
4  1
1  1nts w
typic
Stop
 12
 1
 3
 1
 1
 2
 3swer “yes” when asked if they experience leg pain while
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the perception of an ordinary pace and differences in indi-
vidual walking paces may affect the answer. Patients who
perceive an ordinary pace as slow, or who walk slowly at
their preferred speed, may be less likely to report leg pain
than those who perceive an ordinary pace as fast, or who
walk fast.
Differences in walking pace may also affect the patient’s
response when asked if the leg pain ever disappears while
walking. To be defined as having classic intermittent clau-
dication, patients must answer “no,” but that answer may
depend on whether the walking pace changes after the
onset of pain. Patients who slow their walking pace once leg
pain occurs may experience pain relief and, consequently,
are defined as having atypical pain. These patients may
actually have classic intermittent claudication but are simply
misclassified because they slow their walking pace to relieve
leg pain rather than their pain disappearing in some atypical
fashion. In contrast, those who continue walking at the
same pace after the onset of leg pain may not experience
pain relief as they continue to walk and thus are defined as
having classic intermittent claudication. Finally, many pa-
tients may not walk enough or be sufficiently attentive to
the conditions that produce exertional leg pain to accu-
rately describe their symptoms.
Despite a similar exercise performance and a similar
ischemic window response to standardized treadmill exer-
cise in the four groups, the patients with leg pain on
exertion and rest had the lowest values for the 6-minute
walking distance, Short Physical Performance Battery
score, and daily physical activity. The 6-minute walking
distance for the patients who reported leg pain on exertion
and rest was 34 meters shorter than for patients with
intermittent claudication. This supports a previous report
showing the former group to have a shorter 6-minute walk
distance of 37 meters.20 The shorter 6-minute walk dis-
tance in those with leg pain on exertion and rest compared
with those with intermittent claudication cannot be attrib-
uted to worse exertional leg pain because both groups had
a similar pain-free walking distance during the 6-minute
walk test as well as similar ICD and ACD values during a
standardized treadmill test. Furthermore, the difference in
the 6-minute walk distance between the groups is not due
to differences in peripheral vascular insufficiency because
the ABI, ischemic window, calf blood flow, and TcPO2
measures were similar in all groups. In fact, the ABI of
patients with leg pain on exertion and rest was higher than
in those with intermittent claudication in the previous
study.20
The lower 6-minute walk distance, Short Physical Per-
formance Battery score, and daily physical activity in pa-
tients with leg pain on exertion and rest suggests that they
have further impairment in lower extremity muscular en-
durance and function unrelated to the severity of PAD
symptoms and disease severity. Thus, patients who report
any pain at rest are more functionally dependent than
patients who experience pain only on exertion, regardless of
whether the pain is typical of intermittent claudication. Itshould be recognized, however, that the patients who
reported any pain at rest in the current study did not have
more advanced PAD, which would have placed them in a
more advanced Fontaine classification stage. Patients with
rest pain according to Fontaine stage III PAD typically have
ABI values much lower than the patients in this investiga-
tion, reflecting more severe chronic ischemia in the lower
extremity that eventually leads to tissue loss or gangrene.
This was clearly not the case for those who reported having
leg pain on exertion and rest and indicates the rest pain was
not due to a more advanced level of PAD.
Our study supports previous work that patients with leg
pain on exertion and rest have the worst performance on
each component of the Short Physical Performance Bat-
tery,20 which includes a prolonged time to complete five
sequential sit-to-stand transfers, impaired ability to hold a
full tandem stand, and a slower walking velocity over a
distance of 4 meters.20 These differences in physical func-
tion may partially explain or be a consequence of the 20%
lower monitored physical activity level of the patients with
leg pain on exertion and rest compared with those with
intermittent claudication as well as the 27% lower self-
reported physical activity level. The difference inmonitored
physical activity is similar to the 21% difference between the
groups in a previous report,20 although this difference was
not significant, perhaps due to the smaller group sample
sizes than this study.
This study has limitations that deserve mention. The
results are generalizable to PAD patients with a history of
leg pain and who are limited by leg pain during a standard-
ized treadmill test, regardless of whether the leg pain is
typical or atypical of intermittent claudication. Thus, the
present findings cannot be generalized to patients with
asymptomatic PAD or to those who are limited in their
exercise performance by other significant comorbid condi-
tions.
Another limitation is that most of the participants were
veterans, and consequently, approximately 80% of the sam-
ple was men. However African Americans were well repre-
sented in this sample as were patients with typical risk
factors for PAD, including smoking, diabetes, hyperten-
sion, hyperlipidemia, and obesity. Thus, in patients limited
by leg pain, the findings of the present study are generaliz-
able to the large proportion with numerous comorbid
conditions.
A final limitation is that the analyses did not control for
medications such as statins. We believe, however, that
medication usage had minimal influence on the results of
this study because the proportion of those with diabetes,
hypertension, and hyperlipidemia were remarkably similar
among the four leg pain groups.
CONCLUSION
The clinical relevance of this study is that PAD
patients who have leg symptoms atypical from classic
intermittent claudication have vascular-mediated limita-
tions in exercise performance during standardized tread-
mill testing similar to those patients with intermittent
JOURNAL OF VASCULAR SURGERY
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patients should be viewed as having similar consequences
on exercise performance as that of classic intermittent
claudication. Although the subtype of exertional leg pain
in PAD patients has little impact on standardized exer-
cise performance, it is not clear whether patients with
different types of exertional leg pain have different re-
sponses to treatment interventions designed to improve
ambulatory function. Such intervention trials are
needed.
PAD patients with different types of exertional leg
pain, all limited by intermittent claudication during a
standardized treadmill test, were remarkably similar in
ICD, ACD, and ischemic window. Thus, we conclude
that the presence of ambulatory symptoms should be of
primary clinical concern in evaluating PAD patients re-
gardless of whether they are consistent with classic inter-
mittent claudication.
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